Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
- 1 October 2000
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 18 (10), 412-420
- https://doi.org/10.1016/s0167-7799(00)01485-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Photooxidative degradation of polyether-based polymersMacromolecular Symposia, 1999
- Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymerLife Sciences, 1999
- Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarctionAmerican Heart Journal, 1998
- Pluronid® F-68 Inhibits Agonist-Induced Platelet Aggregation in Human Whole Blood in VitroArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1998
- Multidrug transporters from bacteria to man: similarities in structure and functionSeminars in Cancer Biology, 1997
- Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clotsBlood Coagulation & Fibrinolysis, 1996
- Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodesFEBS Letters, 1994
- Physical Basis for Poloxamer InteractionsAnnals of the New York Academy of Sciences, 1994
- Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coatingBiochemical and Biophysical Research Communications, 1991
- The Adjuvant Activity of Nonionic Block Polymer Surfactants.Scandinavian Journal of Immunology, 1986